Occudo Quantitative Strategies LP Voyager Therapeutics, Inc. Transaction History

Occudo Quantitative Strategies LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$5.57 - $7.47 $53,243 - $71,405	-9,559 Reduced 26.44%	26,593 $157,000
Q2 2022 Aug 15, 2022	BUY	$4.82 - $10.09 $104,878 - $219,548	21,759 Added 151.18%	36,152 $214,000
Q1 2022 May 16, 2022	BUY	$2.75 - $9.44 $39,580 - $135,869	14,393 New	14,393 $110,000
Q4 2021 Feb 14, 2022	SELL	$2.47 - $5.55 $39,690 - $89,182	-16,069 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$2.63 - $4.12 $13,846 - $21,691	-5,265 Reduced 24.68%	16,069 $42,000
Q2 2021 Aug 16, 2021	BUY	$3.94 - $5.44 $84,055 - $116,056	21,334 New	21,334 $88,000

130

34.7M

39.7K

34.6K

Ticker VYGR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,647,600
Market Cap $223M
Description
Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...

Get notified when there are updates to the investment portfolio of Occudo Quantitative Strategies LP, based on Form 13F filings with the SEC.

Stay updated on Occudo Quantitative Strategies LP with notifications on news.